Cited by 273Mast cells and histamineTissue Engineering and Regenerative MedicineOrthopaedic implants and arthroplasty

Mast cells mediate acute inflammatory responses to implanted biomaterials

Open access
Tang, Liping, Jennings, Timothy A., Eaton, John W.·1998·Proceedings of the National Academy of Sciences

Abstract

Implanted biomaterials trigger acute and chronic inflammatory responses. The mechanisms involved in such acute inflammatory responses can be arbitrarily divided into phagocyte transmigration, chemotaxis, and adhesion to implant surfaces. We earlier observed that two chemokines-macrophage inflammatory protein 1alpha/monocyte chemoattractant protein 1-and the phagocyte integrin Mac-1 (CD11b/CD18)/surface fibrinogen interaction are, respectively, required for phagocyte chemotaxis and adherence to biomaterial surfaces. However, it is still not clear how the initial transmigration of phagocytes through the endothelial barrier into the area of the implant is triggered. Because implanted biomaterials elicit histaminic responses in the surrounding tissue, and histamine release is known to promote rapid diapedesis of inflammatory cells, we evaluated the possible role of histamine and mast cells in the recruitment of phagocytes to biomaterial implants. Using i.p. and s. c. implantation of polyethylene terephthalate disks in mice we find: (i) Extensive degranulation of mast cells, accompanied by histamine release, occurs adjacent to short-term i.p. implants. (ii) Simultaneous administration of H1 and H2 histamine receptor antagonists (pyrilamine and famotidine, respectively) greatly diminishes recruitment and adhesion of both neutrophils (<20% of control) and monocytes/macrophages (<30% of control) to implants. (iii) Congenitally mast cell-deficient mice also exhibit markedly reduced accumulation of phagocytes on both i.p. and s.c implants. (iv) Finally, mast cell reconstitution of mast cell-deficient mice restores "normal" inflammatory responses to biomaterial implants. We conclude that mast cells and their granular products, especially histamine, are important in recruitment of inflammatory cells to biomaterial implants. Improved knowledge of such responses may permit purposeful modulation of both acute and chronic inflammation affecting implanted biomaterials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.95.15.8841

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recruitment of inflammatory cells is mediated by mast cells, which secrete granular products that attract and promote adhesion of monocytes and macrophages to the implant.

    “The recruitment is mediated by mast cells, which secrete granular products that attract and promote the adhesion of monocytes and macrophages to the implant.[ 34 ]”

    From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [34]

    The Abstract reports that mast cells and their granular products, especially histamine, are important in recruiting inflammatory cells to implants. The Discussion distinguishes that role from chemotaxis toward the implant, which it attributes to chemokines, and adhesion to the implant surface, which it attributes at least partly to phagocyte Mac-1 binding surface fibrinogen. Thus, the source does not support assigning attraction and implant-surface adhesion to mast-cell granular products. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Mast cell degranulation with histamine release and fibrinogen adsorption mediates acute inflammatory responses to implanted biomaterials.

    “Mast cell degranulation with histamine release and fibrinogen adsorption is known to mediate acute inflammatory responses to implanted biomaterials.[6, 7]”

    From Foreign body reaction to biomaterials (2008) · cites this paper as [7]

  • Mast cell degranulation and release of histamine plays an integral role in recruiting phagocytes, including macrophages, to the site of the implanted biomaterial.

    “In addition, mast cell degranulation and release of histamine has been shown to play an integral role in recruiting phagocytes, including macrophages, to the site of the implanted biomaterial.[7]”

    From Foreign body reaction to biomaterials (2008) · cites this paper as [7]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. [2]Tang L, Lucas A H, Eaton J W. J Lab Clin Med. 1993;122:292–300. [PubMed] [Google Scholar]
  2. [8]Santavirta S, Konttinen Y T, Bergroth V, Eskola A, Tallroth K, Lindholm S. J Bone Joint Surg. 1990;72:252–258. [PubMed] [Google Scholar]
  3. [14]Chan S C, Birdsell D C, Gradeen C Y. Clin Chem. 1991;37:756–758. [PubMed] [Google Scholar]
  4. [22]Guo W, Willen R, Andersson R, Parsson H, Liu X, Johansson K, Bengmark S. Int J Artif Organs. 1993;16:276–284. [PubMed] [Google Scholar]
  5. [26]Kubes P, Kanwar S. J Immunol. 1994;152:3570–3577. [PubMed] [Google Scholar]
  6. [28]Yates S G, II, Nakagawa Y, Berger K, Sauvage L R. Surg Gynecol Obstet. 1973;136:12–16. [PubMed] [Google Scholar]
  7. [34]Irman-Florjanc, T. & Erjavec, F. (1994) Agents Actions 41, special issue, C129–C130. [DOI] [PubMed]
  8. [40]Reiner E, Aldridge W N, Hoskin F C G. Enzyme Hydrolysing Organophosphorous Compounds. New York: Horwood; 1989. p. 266. [Google Scholar]
  9. [43]Kaneta S, Yanaguimoto H, Kagaya J, Ishizuki S, Fujihira E. Res Commun Chem Pathol Pharmacol. 1993;79:167–184. [PubMed] [Google Scholar]
  10. [47]Kitamura Y, Go S, Hatanaka K. Blood. 1978;52:447–452. [PubMed] [Google Scholar]
  11. [49]Ebbe S, Phalen E, Stohlman F., Jr Blood. 1973;42:857–864. [PubMed] [Google Scholar]
  12. [50]Wershil B K, Murakami T, Galli S J. J Immunol. 1988;140:2356–2360. [PubMed] [Google Scholar]
  13. [51]Ramos B F, Qureshi R, Olsen K M, Jakschik B A. J Immunol. 1990;145:1868–1873. [PubMed] [Google Scholar]
  14. [52]Ramos B F, Zhang Y, Qureshi R, Jakschik B A. J Immunol. 1991;147:1636–1641. [PubMed] [Google Scholar]
  15. [53]Ramos B F, Zhang Y, Angkachatchai V, Jakschik B A. J Pharmacol Exp Ther. 1992;262:559–565. [PubMed] [Google Scholar]
  16. [54]Wei Y, Heghinian K, Bell R, Jakschik B A. J Immunol. 1986;137:1993–2000. [PubMed] [Google Scholar]
  17. [57]Asako H, Kurose I, Wolfe R, DeFrees S, Zheng Z-L, Philips M L, Paulson J C, Granger D N. J Clin Invest. 1994;93:1508–1515. doi: 10.1172/JCI117129. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  18. [58]Kubes P, Kanwar S. J Immunol. 1994;152:3570–3577. [PubMed] [Google Scholar]
  19. [60]Okamoto H, Nakano K. Immunology. 1990;69:162–165. [PMC free article] [PubMed] [Google Scholar]
  20. [67]Issekutz A C. Lab Invest. 1981;45:234–240. [PubMed] [Google Scholar]
  21. [69]Grega G J, Adamski S W. Microcirc Endothel Lymph. 1991;7:267–291. [PubMed] [Google Scholar]
  22. [71]Hattori R, Hamilton K K, Fugate R D, McEver B R, Sims P J. J Biol Chem. 1989;264:7768–7771. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Tang, L., Jennings, T. A., & Eaton, J. W.
Affiliations
Baylor College of Medicine (US)
Venue
Proceedings of the National Academy of Sciences
Published
1998-07-21
Volume
95
Issue
15
Pages
8841-8846
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2037046845
Cited by
272
References
78
Citations by year
2026: 1 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 18 · 2020: 19 · 2019: 8 · 2018: 11 · 2017: 19 · 2016: 16 · 2015: 12 · 2014: 8 · 2013: 14 · 2012: 8
FWCI
1.56
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Surgery › Orthopaedic implants and arthroplasty
Keywords
mast cells, histamine, biomaterial implantation, acute inflammation, phagocyte recruitment, neutrophil transmigration, monocyte adhesion, histamine H1 receptor antagonists, H2 receptor antagonists, mast cell-deficient mice, transendothelial migration, macrophage inflammatory protein-1alpha, Mac-1
MeSH terms
Animals, Biocompatible Materials, Histamine, Histamine Release, Inflammation, Mast Cells, Phagocytes, Cell Degranulation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review